id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-2321-0002,FDA,FDA-2014-E-2321,Patent Extension Application from Hyperion on Behalf of Brusilow Enterprises LLC,Other,Application,2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2015-01-07T22:00:23Z,,0,0,090000648199acc9
FDA-2014-E-2321-0001,FDA,FDA-2014-E-2321,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2014-12-30T05:00:00Z,2014,12,2014-12-30T05:00:00Z,,2014-12-30T22:10:34Z,,0,0,090000648199ab9e